Home
Search
Search Results
Previously Searched
3114 results found
Expand All
Apply All
3114 results found

CEOs to Congress: Pass ORPHAN Cures Act
Good Day BIO Newsletter  •  February 28, 2024
BIO members and CEOs sent a letter to congressional leaders urging them to pass the ORPHAN Cures Act and support rare disease R&D. Plus, more highlights from the BIO CEO and Investor Conference, including what executives are saying about the policy outlook and AI. (676 words, 3 minutes, 22 seconds)
Read More

BIO CEO & Investor Conference (Day 2)
February 27, 2024
Participate in the BIO CEO & Investor Conference, one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. Don't miss your opportunity to: Find and request meetings with potential partners using the BIO One-on-One Partnering™ system Discover the latest innovations in biotech during Company Presentations Hear from thought-leaders during sessions on therapeutic advancements, market outlook, and policy priorities Past speakers include MDs, CSOs and industry analysts discussing the latest information on pipeline innovation along with industry executives and analysts who delve into timely and relevant business models, deal-making, and investment trends. Download the 2023 Program Guide to see the caliber of sessions you can expect at the event.
Read More

I am BIO Podcast (Old)

Is CRISPR the new sickle cell savior?
Good Day BIO Newsletter  •  February 27, 2024
On Day 1 of the BIO CEO and Investor Conference, CEOs and experts explained why it’s a great time to invest in innovations such as gene therapy and vaccines. Meanwhile, the I am BIO Podcast launches its new season with a look at the first approved CRISPR-based gene therapy and its impact on sickle cell patients. (780 words, 3 minutes, 54 seconds)
Read More

Biotech Companies Urge Congress to Pass Bipartisan ORPHAN Cures Act
Human Health, Orphan & Rare Diseases  •  Letters, Testimony & Comments  •  February 27, 2024
We are writing to express our strong support for the bipartisan Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act). The legislation, which was introduced by Reps. John Joyce (R-PA) and Wiley Nickel (D-NC) in September,1 corrects a significant flaw in the Inflation Reduction Act (IRA) concerning medicines for rare diseases. Senators Tom Carper (D- DE) and John Barrasso, M.D., (R-WY) introduced the Senate companion to the legislation.
Read More

Is CRISPR the New Sickle Cell Savior?
I am BIO Podcast  •  February 27, 2024
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients. 
Read More
podcast

BIO Videos

BIO CEO & Investor Conference (Day 1)
February 26, 2024
Participate in the BIO CEO & Investor Conference, one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. Don't miss your opportunity to: Find and request meetings with potential partners using the BIO One-on-One Partnering™ system Discover the latest innovations in biotech during Company Presentations Hear from thought-leaders during sessions on therapeutic advancements, market outlook, and policy priorities Past speakers include MDs, CSOs and industry analysts discussing the latest information on pipeline innovation along with industry executives and analysts who delve into timely and relevant business models, deal-making, and investment trends. Download the 2023 Program Guide to see the caliber of sessions you can expect at the event.
Read More

WTO, BIO CEO, and Rare Disease Week begin
Good Day BIO Newsletter  •  February 26, 2024
It’s a big week—with the BIO CEO and Investor Conference kicking off in New York, Rare Disease Week happening in D.C., and the World Trade Organization (WTO) Ministerial in Abu Dhabi. Here’s what we’re watching—follow along all week! (785 words, 3 minutes, 55 seconds)
Read More

Joint statement from pharmaceutical trade bodies on the WTO TRIPS Waiver and upcoming WTO 13th Ministerial Conference
Intellectual Property, Human Health  •  Letters, Testimony & Comments  •  February 23, 2024
The meeting of global trade ministers at the World Trade Organization’s 13th Ministerial Conference in Abu Dhabi offers an important opportunity to build on and strengthen the open and rules-based international trading system to support better health outcomes for people across the world and help address future health crises...
Read More